India · Delayed Price · Currency is INR Heartland Financial USA Statistics
Total Valuation
Biocon has a market cap or net worth of INR 458.18 billion. The enterprise value is 656.83 billion.
| Market Cap | 458.18B |
| Enterprise Value | 656.83B |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
| Current Share Class | 1.33B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 583.07M |
Valuation Ratios
The trailing PE ratio is 119.01 and the forward PE ratio is 49.70.
| PE Ratio | 119.01 |
| Forward PE | 49.70 |
| PS Ratio | 2.91 |
| PB Ratio | 1.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 170.61 |
| EV / Sales | 4.16 |
| EV / EBITDA | 19.99 |
| EV / EBIT | 40.50 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 5.59 |
| Debt / FCF | n/a |
| Interest Coverage | 1.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 2.31% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 9.67M |
| Profits Per Employee | 235,979 |
| Employee Count | 16,315 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Biocon has paid 1.81 billion in taxes.
| Income Tax | 1.81B |
| Effective Tax Rate | 21.62% |
Stock Price Statistics
The stock price has increased by +5.07% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +5.07% |
| 50-Day Moving Average | 366.61 |
| 200-Day Moving Average | 350.26 |
| Relative Strength Index (RSI) | 31.30 |
| Average Volume (20 Days) | 188,682 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biocon had revenue of INR 157.71 billion and earned 3.85 billion in profits. Earnings per share was 3.21.
| Revenue | 157.71B |
| Gross Profit | 95.31B |
| Operating Income | 16.22B |
| Pretax Income | 8.38B |
| Net Income | 3.85B |
| EBITDA | 32.26B |
| EBIT | 16.22B |
| Earnings Per Share (EPS) | 3.21 |
Balance Sheet
The company has 45.65 billion in cash and 183.62 billion in debt, giving a net cash position of -137.97 billion.
| Cash & Cash Equivalents | 45.65B |
| Total Debt | 183.62B |
| Net Cash | -137.97B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 277.13B |
| Book Value Per Share | 180.66 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 60.43%, with operating and profit margins of 10.28% and 2.44%.
| Gross Margin | 60.43% |
| Operating Margin | 10.28% |
| Pretax Margin | 5.31% |
| Profit Margin | 2.44% |
| EBITDA Margin | 20.46% |
| EBIT Margin | 10.28% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.14%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | 0.03% |
| Earnings Yield | 0.84% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Jun 12, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |